|
Volumn 4, Issue 1, 2002, Pages 31-38
|
Economic evaluation of oral capecitabine vs intravenous 5-fluorouracil plus leucovorin (Mayo regimen) in the treatment of advanced colorectal cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPECITABINE;
FLUOROURACIL;
FOLINIC ACID;
ADVANCED CANCER;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST CONTROL;
COST MINIMIZATION ANALYSIS;
DIARRHEA;
ECONOMIC EVALUATION;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HEALTH SERVICE;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
INFECTION;
INFORMATION PROCESSING;
ITALY;
MAJOR CLINICAL STUDY;
MEDICAL RECORD;
NEUTROPENIA;
PATIENT REFERRAL;
PHASE 3 CLINICAL TRIAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SEPSIS;
STOMATITIS;
VOMITING;
|
EID: 0036259375
PISSN: 15909158
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03320592 Document Type: Article |
Times cited : (10)
|
References (19)
|